Year |
Citation |
Score |
2020 |
Bridges E, Sheldon H, Kleibeuker E, Ramberger E, Zois C, Barnard A, Harjes U, Li JL, Masiero M, MacLaren R, Harris A. RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Angiogenesis. PMID 32506201 DOI: 10.1007/S10456-020-09726-W |
0.408 |
|
2019 |
Lord SR, Collins JM, Cheng WC, Haider S, Wigfield S, Gaude E, Fielding BA, Pinnick KE, Harjes U, Segaran A, Jha P, Hoefler G, Pollak MN, Thompson AM, Roy PG, et al. Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin. British Journal of Cancer. PMID 31819193 DOI: 10.1038/s41416-019-0665-5 |
0.457 |
|
2017 |
Treps L, Conradi LC, Harjes U, Carmeliet P. Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? Pharmacological Reviews. 68: 872-87. PMID 27363442 DOI: 10.1124/pr.116.012492 |
0.328 |
|
2015 |
Harjes U, Kalucka J, Carmeliet P. Targeting fatty acid metabolism in cancer and endothelial cells. Critical Reviews in Oncology/Hematology. 97: 15-21. PMID 26558689 DOI: 10.1016/j.critrevonc.2015.10.011 |
0.369 |
|
2014 |
Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. The Journal of Biological Chemistry. 289: 23168-76. PMID 24939870 DOI: 10.1074/jbc.M114.576512 |
0.539 |
|
Low-probability matches (unlikely to be authored by this person) |
2018 |
Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW, Carmeliet P. Endothelial Cell Metabolism. Physiological Reviews. 98: 3-58. PMID 29167330 DOI: 10.1152/physrev.00001.2017 |
0.256 |
|
2018 |
Kalucka J, Bierhansl L, Conchinha NV, Missiaen R, Elia I, Brüning U, Scheinok S, Treps L, Cantelmo AR, Dubois C, de Zeeuw P, Goveia J, Zecchin A, Taverna F, Morales-Rodriguez F, ... ... Harjes U, et al. Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis. Cell Metabolism. PMID 30146488 DOI: 10.1016/J.Cmet.2018.07.016 |
0.237 |
|
2017 |
Harjes U, Verfaillie C, Carmeliet P. Endothelial Barrier and Metabolism: New Kids on the Block Regulating Bone Marrow Vascular Niches. Developmental Cell. 37: 210-2. PMID 27165553 DOI: 10.1016/J.Devcel.2016.04.016 |
0.197 |
|
2021 |
Harjes U. SETDB1, a new target for immunotherapy. Nature Reviews. Cancer. 21: 412. PMID 34083782 DOI: 10.1038/s41568-021-00373-x |
0.188 |
|
2019 |
Harjes U. Context determines which pathway to use for NAD synthesis. Nature Reviews. Cancer. 19: 365. PMID 31138903 DOI: 10.1038/s41568-019-0157-1 |
0.185 |
|
2018 |
Harjes U. Breast cancer: Staying silent. Nature Reviews. Cancer. 18: 136. PMID 29467524 DOI: 10.1038/nrc.2018.17 |
0.185 |
|
2022 |
Harjes U. A trojan horse to target spliceosome mutant cells. Nature Reviews. Cancer. 22: 257. PMID 35338309 DOI: 10.1038/s41568-022-00472-3 |
0.182 |
|
2021 |
Harjes U. IgA strikes twice in ovarian cancer. Nature Reviews. Cancer. 21: 215. PMID 33627799 DOI: 10.1038/s41568-021-00342-4 |
0.172 |
|
2018 |
Harjes U. Breast cancer: External communication. Nature Reviews. Cancer. 18: 372-373. PMID 29610491 DOI: 10.1038/nrc.2018.30 |
0.158 |
|
2017 |
Harjes U. Cancer: Beyond the C. Nature Reviews. Drug Discovery. 16: 678-679. PMID 28959947 DOI: 10.1038/nrd.2017.200 |
0.141 |
|
2019 |
Harjes U. Mimicking multi-organ drug effects. Nature Reviews. Cancer. 19: 417. PMID 31289373 DOI: 10.1038/s41568-019-0175-z |
0.138 |
|
2018 |
Harjes U. BETting on YAP-TAZ. Nature Reviews. Cancer. 18: 663. PMID 30301931 DOI: 10.1038/s41568-018-0065-9 |
0.13 |
|
2017 |
Harjes U. Tumour biomarkers: A mark is a marker. Nature Reviews. Cancer. 17: 708. PMID 29162947 DOI: 10.1038/nrc.2017.115 |
0.128 |
|
2011 |
Smeets SJ, Harjes U, van Wieringen WN, Sie D, Brakenhoff RH, Meijer GA, Ylstra B. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic! Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4959-64. PMID 21673065 DOI: 10.1158/1078-0432.Ccr-11-0462 |
0.126 |
|
2017 |
Harjes U. Cancer: Ironing it out. Nature Reviews. Drug Discovery. 16: 602. PMID 28860580 DOI: 10.1038/nrd.2017.168 |
0.112 |
|
2020 |
Harjes U. Benevolent viruses in skin cancer. Nature Reviews. Cancer. 20: 2. PMID 31745332 DOI: 10.1038/s41568-019-0229-2 |
0.112 |
|
2020 |
Harjes U. Metabolic ageing drives tumour progression. Nature Reviews. Cancer. 20: 626. PMID 32860014 DOI: 10.1038/s41568-020-00301-5 |
0.094 |
|
2017 |
Harjes U. Non-small cell lung cancer: Where there's smoke... Nature Reviews. Cancer. 17: 634-635. PMID 29026205 DOI: 10.1038/nrc.2017.95 |
0.094 |
|
2019 |
Harjes U. Renovation in progress. Nature Reviews. Cancer. 19: 246. PMID 30890773 DOI: 10.1038/s41568-019-0131-y |
0.093 |
|
2018 |
Harjes U. Gastric cancer: Risk analysis. Nature Reviews. Cancer. 18: 66. PMID 29368743 DOI: 10.1038/nrc.2018.9 |
0.09 |
|
2017 |
Harjes U. Tumour angiogenesis: Controlling nerves. Nature Reviews. Cancer. 17: 708. PMID 29123247 DOI: 10.1038/nrc.2017.107 |
0.084 |
|
2019 |
Harjes U. Leptin boosts T cell function in tumours. Nature Reviews. Cancer. 19: 607. PMID 31527698 DOI: 10.1038/s41568-019-0208-7 |
0.082 |
|
2019 |
Harjes U. T cells pass on the baton during checkpoint inhibition. Nature Reviews. Cancer. 19: 546. PMID 31417201 DOI: 10.1038/s41568-019-0194-9 |
0.08 |
|
2017 |
Harjes U. Tumour immunology: Tumours copy to escape. Nature Reviews. Cancer. 17: 453. PMID 28740113 DOI: 10.1038/nrc.2017.66 |
0.079 |
|
2017 |
Harjes U. Therapeutic resistance: Ironing it out. Nature Reviews. Cancer. 17: 510. PMID 28798485 DOI: 10.1038/nrc.2017.71 |
0.075 |
|
2020 |
Harjes U. Zones of biosynthesis. Nature Reviews. Cancer. 20: 361. PMID 32472072 DOI: 10.1038/s41568-020-0276-8 |
0.072 |
|
2019 |
Harjes U. Every cell counts. Nature Reviews. Cancer. 19: 666. PMID 31673078 DOI: 10.1038/s41568-019-0225-6 |
0.072 |
|
2020 |
Harjes U. Tumour-reactive T cells work remotely using IFNγ. Nature Reviews. Cancer. 20: 261. PMID 32218523 DOI: 10.1038/s41568-020-0255-0 |
0.068 |
|
2017 |
Harjes U. Metabolism: Conscious decoupling. Nature Reviews. Cancer. 17: 708. PMID 29162945 DOI: 10.1038/nrc.2017.113 |
0.067 |
|
2017 |
Harjes U. Metabolism: More lactate, please. Nature Reviews. Cancer. 17: 707. PMID 29077692 DOI: 10.1038/nrc.2017.101 |
0.066 |
|
2018 |
Harjes U. Pap seeking new challenges. Nature Reviews. Cancer. 18: 338-339. PMID 29692416 DOI: 10.1038/s41568-018-0013-8 |
0.065 |
|
2017 |
Harjes U. Leukaemia: Multiple origins of relapse. Nature Reviews. Cancer. 17: 453. PMID 28740118 DOI: 10.1038/nrc.2017.67 |
0.062 |
|
2022 |
Harjes U. Points of entry for tumour-infiltrating lymphocytes. Nature Reviews. Cancer. 22: 194. PMID 35228674 DOI: 10.1038/s41568-022-00460-7 |
0.06 |
|
2019 |
Harjes U. Embryonic factor helps tumours to lie low. Nature Reviews. Cancer. 19: 488. PMID 31391549 DOI: 10.1038/s41568-019-0191-z |
0.058 |
|
2021 |
Harjes U. Antidepressants revive T cells. Nature Reviews. Cancer. 21: 412. PMID 34083783 DOI: 10.1038/s41568-021-00374-w |
0.057 |
|
2020 |
Harjes U. The source within - intratumoural stem-like T cells give rise to differentiated T cells. Nature Reviews. Cancer. 20: 140. PMID 31925398 DOI: 10.1038/s41568-020-0239-0 |
0.055 |
|
2019 |
Harjes U. Dividing paths in fatty liver disease. Nature Reviews. Cancer. 19: 5. PMID 30451985 DOI: 10.1038/s41568-018-0086-4 |
0.054 |
|
2020 |
Harjes U. One foot in the door: gene gating supports nuclear export of MYC mRNA. Nature Reviews. Cancer. 20: 71. PMID 31875030 DOI: 10.1038/s41568-019-0236-3 |
0.051 |
|
2021 |
Harjes U. The neuronal-metabolic interface. Nature Reviews. Cancer. 21: 68. PMID 33262455 DOI: 10.1038/s41568-020-00324-y |
0.048 |
|
2018 |
Harjes U. Metabolism: Fusion power. Nature Reviews. Cancer. 18: 66. PMID 29368747 DOI: 10.1038/nrc.2018.2 |
0.046 |
|
2022 |
Harjes U. Glycogen condensates drive tumorigenesis by trapping Hippo kinases. Nature Reviews. Cancer. 22: 1. PMID 34848861 DOI: 10.1038/s41568-021-00430-5 |
0.046 |
|
2019 |
Harjes U. E-selectin fills two needs for metastasis. Nature Reviews. Cancer. 19: 301. PMID 31065050 DOI: 10.1038/s41568-019-0151-7 |
0.044 |
|
2022 |
Harjes U. Parity modulates epithelial-immune cell communication. Nature Reviews. Cancer. 22: 130. PMID 35110730 DOI: 10.1038/s41568-022-00449-2 |
0.043 |
|
2020 |
Harjes U. Germline control of anti-tumour immunity. Nature Reviews. Cancer. 20: 414. PMID 32555350 DOI: 10.1038/s41568-020-0282-x |
0.042 |
|
2018 |
Harjes U. Stress management in T cells. Nature Reviews. Cancer. 18: 724-725. PMID 30451983 DOI: 10.1038/s41568-018-0082-8 |
0.041 |
|
2018 |
Harjes U. Epigenetic control by sugar. Nature Reviews. Cancer. 18: 598-599. PMID 30158651 DOI: 10.1038/s41568-018-0052-1 |
0.038 |
|
2017 |
Harjes U. Metastasis: Throwing oil into the flames. Nature Reviews. Cancer. 17: 510-511. PMID 28835718 DOI: 10.1038/nrc.2017.76 |
0.036 |
|
2019 |
Harjes U. Maintaining the tumour's diet. Nature Reviews. Cancer. 19: 62-63. PMID 30610214 DOI: 10.1038/s41568-018-0097-1 |
0.033 |
|
2021 |
Harjes U. Ammonia recyclers. Nature Reviews. Cancer. PMID 34702983 DOI: 10.1038/s41568-021-00419-0 |
0.029 |
|
2021 |
Harjes U. Bumps in the road lead to immunogenicity. Nature Reviews. Cancer. 21: 142. PMID 33462502 DOI: 10.1038/s41568-021-00334-4 |
0.026 |
|
2019 |
Harjes U. Platelets with dangerous cargo. Nature Reviews. Cancer. 19: 302. PMID 31036885 DOI: 10.1038/s41568-019-0146-4 |
0.025 |
|
2018 |
Harjes U. Immunotherapy: Tear down this wall. Nature Reviews. Immunology. 18: 221. PMID 29545641 DOI: 10.1038/nri.2018.20 |
0.025 |
|
2018 |
Harjes U. Immunotherapy: Tear down this wall. Nature Reviews. Cancer. 18: 205. PMID 29520089 DOI: 10.1038/nrc.2018.22 |
0.025 |
|
2020 |
Harjes U. Metabolites going up in smoke. Nature Reviews. Cancer. 20: 482. PMID 32636490 DOI: 10.1038/s41568-020-0289-3 |
0.024 |
|
2018 |
Harjes U. On the cutting edge. Nature Reviews. Cancer. 18: 404-405. PMID 29713084 DOI: 10.1038/s41568-018-0017-4 |
0.021 |
|
2017 |
Harjes U. Tumour vaccines: Personal training by vaccination. Nature Reviews. Immunology. 17: 468. PMID 28749456 DOI: 10.1038/nri.2017.88 |
0.021 |
|
2017 |
Harjes U. Tumour vaccines: Personal training by vaccination. Nature Reviews. Cancer. 17: 451. PMID 28740114 DOI: 10.1038/nrc.2017.61 |
0.021 |
|
2020 |
Harjes U. The hardiness of liquids. Nature Reviews. Cancer. 20: 551. PMID 32782367 DOI: 10.1038/s41568-020-0296-4 |
0.018 |
|
2019 |
Harjes U. Adapting to change. Nature Reviews. Cancer. 19: 184. PMID 30804499 DOI: 10.1038/s41568-019-0126-8 |
0.018 |
|
2018 |
Harjes U. Success stories. Nature Reviews. Cancer. 18: 465. PMID 29934503 DOI: 10.1038/s41568-018-0039-y |
0.015 |
|
2019 |
Harjes U. Overflow disrupts the genome. Nature Reviews. Cancer. 19: 249. PMID 30926930 DOI: 10.1038/s41568-019-0136-6 |
0.015 |
|
2019 |
Harjes U. Nothing to gain for p53. Nature Reviews. Cancer. 19: 544-545. PMID 31471582 DOI: 10.1038/s41568-019-0202-0 |
0.013 |
|
2021 |
Harjes U. Home advantage for tissue-resident macrophages. Nature Reviews. Cancer. 21: 539. PMID 34294891 DOI: 10.1038/s41568-021-00393-7 |
0.013 |
|
2019 |
Harjes U. Helping tumour antigens to the surface. Nature Reviews. Cancer. 19: 608. PMID 31558838 DOI: 10.1038/s41568-019-0212-y |
0.01 |
|
2021 |
Harjes U. Glutamylation is good for stability. Nature Reviews. Cancer. 21: 479. PMID 34172965 DOI: 10.1038/s41568-021-00385-7 |
0.01 |
|
2021 |
Harjes U. Bacteria prepare the niche. Nature Reviews. Cancer. 21: 342-343. PMID 33859397 DOI: 10.1038/s41568-021-00361-1 |
0.01 |
|
2021 |
Harjes U. EGFR is going circular. Nature Reviews. Cancer. 21: 280. PMID 33758414 DOI: 10.1038/s41568-021-00350-4 |
0.01 |
|
2021 |
Harjes U. Educating macrophages in melanoma. Nature Reviews. Cancer. 21: 4. PMID 33168967 DOI: 10.1038/s41568-020-00317-x |
0.01 |
|
2020 |
Harjes U. Not the usual suspect. Nature Reviews. Cancer. 20: 302. PMID 32376857 DOI: 10.1038/s41568-020-0271-0 |
0.01 |
|
2020 |
Harjes U. How to run through mud. Nature Reviews. Cancer. 20: 201. PMID 32127697 DOI: 10.1038/s41568-020-0250-5 |
0.01 |
|
2019 |
Harjes U. States of exhaustion. Nature Reviews. Cancer. 19: 185. PMID 30846872 DOI: 10.1038/s41568-019-0129-5 |
0.01 |
|
2019 |
Harjes U. Senolytic helpers. Nature Reviews. Cancer. 19: 128-129. PMID 30723289 DOI: 10.1038/s41568-019-0115-y |
0.01 |
|
2019 |
Harjes U. A source of calcium. Nature Reviews. Cancer. 19: 3. PMID 30510212 DOI: 10.1038/s41568-018-0089-1 |
0.01 |
|
2018 |
Harjes U. CAR antigens beyond recognition. Nature Reviews. Immunology. 18: 731. PMID 30367128 DOI: 10.1038/s41577-018-0082-7 |
0.01 |
|
2018 |
Harjes U. CAR antigens beyond recognition. Nature Reviews. Cancer. 18: 723. PMID 30361636 DOI: 10.1038/s41568-018-0075-7 |
0.01 |
|
2018 |
Harjes U. Oncogenic mRNA modification explained. Nature Reviews. Cancer. 18: 667. PMID 30310146 DOI: 10.1038/s41568-018-0068-6 |
0.01 |
|
2018 |
Harjes U. The sugar loop. Nature Reviews. Cancer. 18: 530-531. PMID 30072780 DOI: 10.1038/s41568-018-0049-9 |
0.01 |
|
2018 |
Harjes U. From rock 'n' roll to heavy metal. Nature Reviews. Cancer. 18: 467. PMID 29955121 DOI: 10.1038/s41568-018-0041-4 |
0.01 |
|
2018 |
Harjes U. Immunosurveillance: Presentation skills. Nature Reviews. Cancer. 18: 207. PMID 29563596 DOI: 10.1038/nrc.2018.24 |
0.01 |
|
2018 |
Harjes U. Immunotherapy: Burning fences. Nature Reviews. Cancer. 18: 2. PMID 29192212 DOI: 10.1038/nrc.2017.119 |
0.01 |
|
2017 |
Harjes U. Leukaemia: Crowd control. Nature Reviews. Cancer. 17: 708. PMID 29162943 DOI: 10.1038/nrc.2017.114 |
0.01 |
|
2017 |
Harjes U. Leukaemia: The real deal. Nature Reviews. Cancer. 17: 575. PMID 28943638 DOI: 10.1038/nrc.2017.89 |
0.01 |
|
2017 |
Harjes U. Leukaemia: Beyond the C. Nature Reviews. Cancer. 17: 573. PMID 28883512 DOI: 10.1038/nrc.2017.81 |
0.01 |
|
Hide low-probability matches. |